CompletedPhase 2NCT04654689

Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación Universidad Católica de Valencia San Vicente Mártir
Principal Investigator
José Enrique De la Rubia Ortí, Ph
Catholic University of Valencia
Intervention
Liposomed polyphenols resveratrol and curcumin(dietary_supplement)
Enrollment
90 enrolled
Eligibility
18-75 years · All sexes
Timeline
2021 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04654689 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials